First Solar (FSLR) — Q2 2026 Earnings Preview

Report Date: Thursday, July 30, 2026, after market close | Conference Call: Same day


1. Setup Into the Print

FSLR has been one of the more volatile large-cap industrial names of 2026. The stock started the year near $274, fell into the $185–$200 range after a disappointing FY26 guide on the Q4 print (management's initial 2026 revenue/EBITDA guidance came in below Street expectations, and shares tumbled roughly 14% on that release), then staged a powerful rally to a 52-week high just above $320 in early June on clean-energy sector enthusiasm and hopes for a favorable Section 232 polysilicon tariff ruling. Since that June high, the stock has given back nearly $100/share and closed around $203 heading into this report — since its high of just over $320 on June 4, First Solar's stock has lost just under $100 per share, even as several sell-side firms raised price targets over the same stretch (GLJ Research upgraded from hold to buy to $315 in late May; UBS raised its target to $330 on June 11; Deutsche Bank upgraded to buy at $272 on July 6; Wells Fargo raised its target to $320 on July 6; and Barclays raised its target to $279 on July 13). That disconnect between rising price targets and a falling stock is itself a key tension investors should watch for on the call — is this multiple compression on policy-durability fears, or a healthy digestion after a sharp rally?

2. What Wall Street Expects for Q2

Management's own Q2 framework, issued alongside Q1 results, calls for module sales of 3.4–4.0 GW, Section 45X tax credits of $330–400 million, and Adjusted EBITDA of $400–500 million — a sequential step-down from Q1's $520 million, which management flagged would happen due to lower Malaysia/Vietnam utilization and the roll-off of favorable year-over-year tariff comparisons.

3. Q1 Recap — The Bar This Quarter Must Clear

Q1 2026 was a record quarter operationally: - Net sales of $1.04 billion, up 23.6% year-over-year, driven by a 30.9% increase in module volume sold to third parties, partially offset by lower ASPs tied to a higher mix of India sales. - Gross margin expanded 5.8 points to 46.6%, helped by lower logistics/detention costs and a larger share of modules qualifying for the Section 45X advanced manufacturing credit. - Net income of $346.6 million ($3.22 diluted EPS), up 65% year-over-year. - Adjusted EBITDA of $520 million, above the top end of the company's own $400–500 million preview range. - U.S. manufacturing utilization ran near 96%, and the company reaffirmed full-year 2026 guidance (net sales $4.9–5.2B, gross profit $2.4–2.6B, Adjusted EBITDA $2.6–2.8B, volume sold 17.0–18.2 GW, capex $0.8–1.0B, net cash balance $1.7–2.3B). - Backlog stood at 47.9 GW / $14.4 billion in contracted sales as of March 31, 2026, providing multi-year revenue visibility through 2030. - Balance sheet remained strong: $2.4 billion in cash/marketable securities, $2.0 billion net cash — near the top of the company's target range.

Given that Q2 guidance implies a sequential EBITDA decline, the key question is whether First Solar merely "reiterates" (as it has every quarter this cycle) or delivers another beat-and-hold, which has been the pattern that's supported the stock through 2026's volatility.

4. Policy and Tariff Backdrop — The Real Swing Factor

First Solar's economics are unusually policy-sensitive, and there's a dense set of moving parts investors should track on the call:

5. Bear Case / Overhangs to Watch

6. Bottom Line — What to Watch on the Call

  1. Q2 Adjusted EBITDA vs. the $400–500M guide, and whether the sequential step-down was purely calendar/utilization-driven or reflects incremental tariff/cost pressure.
  2. Full-year 2026 guidance — reiterated, raised, or trimmed (net sales $4.9–5.2B / EBITDA $2.6–2.8B / volume 17.0–18.2 GW are the anchors).
  3. Net bookings and backlog trend from the 47.9 GW/$14.4B base — any material cancellations, renegotiations, or new contracted volume, especially ex-India.
  4. Commentary on the Section 232 polysilicon investigation and the IEEPA tariff refund process, given both remain unresolved policy variables excluded from guidance.
  5. South Carolina finishing facility progress (6th U.S. plant, ~$0.3B investment, targeted for 2H26 start), CuRe technology rollout, and updated U.S. utilization rates.
  6. Any direct response to the securities litigation or added disclosure around tariff mitigation and Malaysia/Vietnam facility utilization.

Given the stock's ~35% pullback from June highs despite a string of price-target increases, this print carries binary-feeling stakes: another "beat-and-reiterate" quarter with constructive bookings commentary could help stabilize sentiment, while any softness in bookings, guidance, or margin bridge — layered on top of the litigation overhang and pending Section 232 decision — could extend the recent slide.